1-10 of 10
Donal J. Brennan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A069: High-resolution volumetric imaging of primary and metastatic high-grade serous ovarian cancer explants

Adele E. Connor, Joanne Lysaght, Donal J. Brennan, Jeremy C. Simpson, Antoinette S. Perry
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A069.
https://doi.org/10.1158/1538-7445.OVARIAN23-A069
Published: 04 March 2024
View article titled, Abstract A069: High-resolution volumetric imaging of primary and metastatic high-grade serous ovarian cancer explants
Journal Articles

Abstract 5033: The role of the epigenetic regulator SATB2 in colon cancer progression

Donal J. Brennan, Kirsha Naicker, Sudipto Das, Bruce Moran, Rut Klinger, Fredrik Ponten, Stephen Hewitt, Karin Jirström, Annette T. Byrne, Jacintha O'Sullivan, William M. Gallagher, Darran P. O'Connor
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 5033.
https://doi.org/10.1158/1538-7445.AM2019-5033
Published: 01 July 2019
View article titled, Abstract 5033: The role of the epigenetic regulator SATB2 in colon cancer progression
Journal Articles

Abstract B83: Targeting tumor-infiltrating macrophages decreases pancreatic tumor-initiating cells and improves chemotherapeutic responses by relieving immune suppression.

Jonathan B. Mitchem, Donal J. Brennan, Dominic E. Sanford, Brett L. Knolhoff, Yu Zhu, Belt Brian, Andrea Wang-Gillam, Peter Goedegebuure, David C. Linehan, David G. DeNardo
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): B83.
https://doi.org/10.1158/1538-7445.TUMIMM2012-B83
Published: 02 April 2014
View article titled, Abstract B83: Targeting tumor-infiltrating macrophages decreases pancreatic tumor-initiating cells and improves chemotherapeutic responses by relieving immune suppression.
Journal Articles

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu, Dominic E. Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica-Worms, Stephen Hewitt, Girish Mallya Udupi, William M. Gallagher, Craig Wegner, Brian L. West, Andrea Wang-Gillam, Peter Goedegebuure, David C. Linehan, David G. DeNardo
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1128–1141.
https://doi.org/10.1158/0008-5472.CAN-12-2731
Published: 31 January 2013
View article titled, Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Open the PDF for Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses in another window
Includes: Supplementary data
Journal Articles

A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Hagen Kulbe, Probir Chakravarty, D. Andrew Leinster, Kellie A. Charles, Joseph Kwong, Richard G. Thompson, Jermaine I. Coward, Tiziana Schioppa, Stephen C. Robinson, William M. Gallagher, Laura Galletta, Michael A. Salako, John F. Smyth, Thorsten Hagemann, Donal J. Brennan, David D. Bowtell, Frances R. Balkwill
Journal: Cancer Research
Cancer Res (2012) 72 (1): 66–75.
https://doi.org/10.1158/0008-5472.CAN-11-2178
Published: 02 January 2012
View article titled, A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Open the PDF for A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment in another window
Includes: Supplementary data
Journal Articles

Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response

Josie Ursini-Siegel, Sean Cory, Dongmei Zuo, William R. Hardy, Elton Rexhepaj, Sonya Lam, Babette Schade, Karin Jirstrom, Eva Bjur, Ciriaco A. Piccirillo, David DeNardo, Lisa M. Coussens, Donal J. Brennan, William M. Gallagher, Morag Park, Tony Pawson, Michael Hallett, William J. Muller
Journal: Cancer Research
Cancer Res (2010) 70 (20): 7776–7787.
https://doi.org/10.1158/0008-5472.CAN-10-2229
Published: 13 October 2010
View article titled, Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response
Open the PDF for Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response in another window
Includes: Supplementary data
Journal Articles

Abstract 3034: miR-224 is marker of poor prognosis in breast cancer

Sharon F. McGee, Laoighse Mulrane, Donal J. Brennan, Susan McDonnell, Karin Jirstrom, Darran P. O'Connor, William M. Gallagher
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3034.
https://doi.org/10.1158/1538-7445.AM10-3034
Published: 15 April 2010
View article titled, Abstract 3034: miR-224 is marker of poor prognosis in breast cancer
Journal Articles

Abstract 4049: MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer

Laoighse Mulrane, Stephen Madden, Donal J. Brennan, Sharon F. McGee, Karin Jirström, Laura van't Veer, Rene Bernards, Des Higgins, William M. Gallagher, Darran P. O'Connor
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4049.
https://doi.org/10.1158/1538-7445.AM10-4049
Published: 15 April 2010
View article titled, Abstract 4049: MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer
Journal Articles

Abstract 1746: Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer

Ehlén Åsa, Donal J Brennan, María Alvarado-Kristensson, Björn Nodin, Darran J O'Connor, Mathias Uhlén, Fredrik Pontén, Karin Jirström
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1746.
https://doi.org/10.1158/1538-7445.AM10-1746
Published: 15 April 2010
View article titled, Abstract 1746: Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
Journal Articles

Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes

Donal J. Brennan, Asa Kronblad*, Karin Jirstrom, Goran Landberg, Michael J. Duffy, William M. Gallagher†, Sallyann L. O Brien
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 847.
Published: 15 April 2006
View article titled, Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes